BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 21994410)

  • 1. Multimodal imaging with (18)F-FDG PET and Cerenkov luminescence imaging after MLN4924 treatment in a human lymphoma xenograft model.
    Robertson R; Germanos MS; Manfredi MG; Smith PG; Silva MD
    J Nucl Med; 2011 Nov; 52(11):1764-9. PubMed ID: 21994410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proof-of-concept study of monitoring cancer drug therapy with cerenkov luminescence imaging.
    Xu Y; Chang E; Liu H; Jiang H; Gambhir SS; Cheng Z
    J Nucl Med; 2012 Feb; 53(2):312-317. PubMed ID: 22241909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (68)Ga-labeled 3PRGD2 for dual PET and Cerenkov luminescence imaging of orthotopic human glioblastoma.
    Fan D; Zhang X; Zhong L; Liu X; Sun Y; Zhao H; Jia B; Liu Z; Zhu Z; Shi J; Wang F
    Bioconjug Chem; 2015 Jun; 26(6):1054-60. PubMed ID: 25853280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraoperative Assessment of Tumor Resection Margins in Breast-Conserving Surgery Using
    Grootendorst MR; Cariati M; Pinder SE; Kothari A; Douek M; Kovacs T; Hamed H; Pawa A; Nimmo F; Owen J; Ramalingam V; Sethi S; Mistry S; Vyas K; Tuch DS; Britten A; Van Hemelrijck M; Cook GJ; Sibley-Allen C; Allen S; Purushotham A
    J Nucl Med; 2017 Jun; 58(6):891-898. PubMed ID: 27932562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerenkov Luminescence Imaging (CLI) for cancer therapy monitoring.
    Xu Y; Liu H; Chang E; Jiang H; Cheng Z
    J Vis Exp; 2012 Nov; (69):e4341. PubMed ID: 23183774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of Cerenkov Luminescence Imaging (CLI) Comparable With 3-D PET Standard Measurements.
    Habte F; Natarajan A; Paik DS; Gambhir SS
    Mol Imaging; 2018; 17():1536012118788637. PubMed ID: 30043654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intratherapeutic biokinetic measurements, dosimetry parameter estimates, and monitoring of treatment efficacy using cerenkov luminescence imaging in preclinical radionuclide therapy.
    Timmermand OV; Tran TA; Strand SE; Axelsson J
    J Nucl Med; 2015 Mar; 56(3):444-9. PubMed ID: 25655628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerenkov Luminescence Imaging as a Modality to Evaluate Antibody-Based PET Radiotracers.
    D'Souza JW; Hensley H; Doss M; Beigarten C; Torgov M; Olafsen T; Yu JQ; Robinson MK
    J Nucl Med; 2017 Jan; 58(1):175-180. PubMed ID: 27539844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of 89Zr-rituximab tracer by Cerenkov luminescence imaging and correlation with PET in a humanized transgenic mouse model to image NHL.
    Natarajan A; Habte F; Liu H; Sathirachinda A; Hu X; Cheng Z; Nagamine CM; Gambhir SS
    Mol Imaging Biol; 2013 Aug; 15(4):468-75. PubMed ID: 23471750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative immuno-Cerenkov luminescence and -PET imaging enables detection of PSMA
    Maier FC; Wild AM; Kirchen N; Holm F; Fuchs K; Schwenck J; Maurer A; Wiehr S
    Appl Radiat Isot; 2019 Jan; 143():149-155. PubMed ID: 30445280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between positron emission tomography and Cerenkov luminescence imaging in vivo and ex vivo using 64Cu-labeled antibodies in a neuroblastoma mouse model.
    Maier FC; Schmitt J; Maurer A; Ehrlichmann W; Reischl G; Nikolaou K; Handgretinger R; Pichler BJ; Thaiss WM
    Oncotarget; 2016 Oct; 7(41):67403-67411. PubMed ID: 27602580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In situ lymphoma imaging in a spontaneous mouse model using the Cerenkov Luminescence of F-18 and Ga-67 isotopes.
    Ritter Z; Zámbó K; Balogh P; Szöllősi D; Jia X; Balázs Á; Taba G; Dezső D; Horváth I; Alizadeh H; Tuch D; Vyas K; Hegedűs N; Kovács T; Szigeti K; Máthé D; Schmidt E
    Sci Rep; 2021 Dec; 11(1):24002. PubMed ID: 34907289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. β-Radioluminescence Imaging: A Comparative Evaluation with Cerenkov Luminescence Imaging.
    King MT; Carpenter CM; Sun C; Ma X; Le QT; Sunwoo JB; Cheng Z; Pratx G; Xing L
    J Nucl Med; 2015 Sep; 56(9):1458-64. PubMed ID: 26205301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerenkov luminescence imaging of interscapular brown adipose tissue using a TSPO-targeting PET probe in the UCP1 ThermoMouse.
    Lee SY; Oh HR; Kim YH; Bae SH; Lee Y; Lee YS; Lee BC; Cheon GJ; Kang KW; Youn H
    Theranostics; 2022; 12(14):6380-6394. PubMed ID: 36168637
    [No Abstract]   [Full Text] [Related]  

  • 15. Intraoperative imaging of tumors using Cerenkov luminescence endoscopy: a feasibility experimental study.
    Liu H; Carpenter CM; Jiang H; Pratx G; Sun C; Buchin MP; Gambhir SS; Xing L; Cheng Z
    J Nucl Med; 2012 Oct; 53(10):1579-84. PubMed ID: 22904353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerenkov luminescence imaging of medical isotopes.
    Ruggiero A; Holland JP; Lewis JS; Grimm J
    J Nucl Med; 2010 Jul; 51(7):1123-30. PubMed ID: 20554722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo optical imaging of interscapular brown adipose tissue with (18)F-FDG via Cerenkov luminescence imaging.
    Zhang X; Kuo C; Moore A; Ran C
    PLoS One; 2013; 8(4):e62007. PubMed ID: 23637947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerenkov imaging.
    Das S; Thorek DL; Grimm J
    Adv Cancer Res; 2014; 124():213-34. PubMed ID: 25287690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptosis imaging probe predicts early chemotherapy response in preclinical models: A comparative study with 18F-FDG PET.
    Song S; Xiong C; Lu W; Ku G; Huang G; Li C
    J Nucl Med; 2013 Jan; 54(1):104-10. PubMed ID: 23283564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Correlation of 3'-deoxy-3'-18F-fluorothymidine uptake to cell proliferation in lung carcinoma xenografts].
    Liu X; Zhou NK; Zhang JM; Liang ZY; Zheng X
    Ai Zheng; 2006 Dec; 25(12):1512-6. PubMed ID: 17166377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.